On Monday, Balaxi Pharmaceuticals Ltd shares surged 19.08% to ₹52. The IPR-based pharma company, with 610 product registrations, reported an 8% increase in Q1FY26 net sales to ₹70.74 crore and a net profit of ₹0.29 crore. FY25 net sales grew 22% to ₹293 crore, with net profit soaring 1,350% to ₹25 crore from a loss.